手法を比較

	ランダム化比較試験のためのコクランのリスク・バイアス評価ツール2.0	PRISMAチェックリスト：システマティックレビューとメタアナリシスの報告基準
分野	研究方法論	研究方法論
系統	Process / pipeline	Process / pipeline
提唱年	2019	2021 (original 2009)
提唱者	Jonathan Sterne, Julian Higgins (Cochrane Collaboration)	Page et al. (PRISMA Group)
種類	Clinician-rated / Research team assessment	Systematic review author reporting checklist
原典	Sterne, J. A., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., ... & Higgins, J. P. (2019). RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ, 366, l4898.	Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71.
別名	RoB 2.0, RoB 2	PRISMA, PRISMA 2020
関連	4	4
概要	RoB 2 is the Cochrane Collaboration's updated methodology for assessing the risk of bias in randomized controlled trials (RCTs). Published in 2019, it replaced the original Cochrane RoB tool with a more structured, transparent approach using signalling questions and domain-based judgments to evaluate five critical sources of bias.	PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is a 27-item evidence-based checklist published in 2021 (updated from 2009) to standardize reporting of systematic reviews and meta-analyses. Endorsed by over 500 journals, PRISMA is the international standard for evidence synthesis reporting, used across healthcare, psychology, education, and social sciences to ensure transparency and reproducibility.